By contrast, the profound RAD51 recruitment defects that characterized human BARD1∆/∆ HCT-116 cells and murine KB1P tumor cells were only slightly ameliorated in shieldin-inactivated derivative cell lines. The gene discussed is RAD51; the disease is neoplasm.